‌

US Patent 10370374 Heterocyclic compounds and uses thereof

Patent 10370374 was granted and assigned to Plexxikon Inc. on August, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Wayne Spevak0

Jiazhong Zhang0

Prabha N. Ibrahim0

Songyuan Shi0

Yan Ma0

Ben Powell0

Date of Patent

August 6, 2019

0

Patent Application Number

159777720

Date Filed

May 11, 2018

0

Patent Citations Received

US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor

0

US Patent 10793561 1,8-naphthyridinone compounds and uses thereof

US Patent 10899761 Heterocyclic compounds and uses thereof

0

US Patent 11584756 Heterocyclic compounds as BET inhibitors

0

US Patent 11028058 Heterocyclic compounds as adenosine antagonists

0

US Patent 11254670 1,8-naphthyridinone compounds and uses thereof

US Patent 11628176 Combinational drug therapies

0

US Patent 11306071 Heterocyclic compounds as adenosine antagonists

...

Patent Primary Examiner

Charanjit Aulakh

0

Patent abstract

Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their preparation, intermediate compounds, pharmaceutical compositions containing such a compound, and their therapeutic uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10370374 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.